Podcast
Tom Caravela: Marieke Jonkman
Career Longevity: What behavioral competencies will help you have career longevity and stability
Summary
In this episode, Norwood Harris shares his extensive experience and career journey at Sandoz and Novartis, providing insights into career longevity and navigating mergers within large and small companies. He emphasizes the importance of networking and building strong internal relationships, alongside the critical role of management in supporting MSLs. Norwood offers practical advice on managing your manager, preparing for performance reviews, and honing presentation skills. He also discusses the significance of passion and networking in interview preparation. The episode concludes with Norwood's guidance on building a stable MSL career, followed by closing remarks and a call to action.
Today my guest is Norward Harris, Consultant Medical Science Liaison Trainer, Professional Mentor, and Original MSL. We discuss MSL career development behavioral competencies that will help you obtain a career of longevity and stability.
In this episode we discuss:
- Norward’s background
- His advice on career longevity and stability
- What role management plays in supporting him as an MSL in his career
- Ways MSLs can be proactive in influencing career stability and longevity
- Advice for MSLs to prepare for Performance Review
- Advice or suggestion for MSLs looking for promotion
- His suggestions to individuals looking to transition to the industry and break into the MSL role
Norwood Harris, MSL career development, networking in MSL roles, managing performance reviews, career longevity in pharma
Related Topics
You May Also Like
Tom Caravela: Marieke Jonkman
Podcast
MSL Talk: Tom Caravela, Sarah Snyder
Power of Podcasts: 3 Surprising Ways MSLs can Level Up By Tuning In
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary